Drug Type Small molecule drug |
Synonyms Barasertib-HQPA, AZD-1152, AZD1152 |
Target |
Mechanism Aurora B inhibitors(Serine/threonine-protein kinase Aurora-B inhibitors) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC26H31FN7O6P |
InChIKeyGBJVVSCPOBPEIT-UHFFFAOYSA-N |
CAS Registry722543-31-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Phase 3 | US | 01 Jul 2009 | |
Acute Myeloid Leukemia | Phase 3 | JP | 01 Jul 2009 | |
Acute Myeloid Leukemia | Phase 3 | AU | 01 Jul 2009 | |
Acute Myeloid Leukemia | Phase 3 | FR | 01 Jul 2009 | |
Acute Myeloid Leukemia | Phase 3 | DE | 01 Jul 2009 | |
Acute Myeloid Leukemia | Phase 3 | IT | 01 Jul 2009 | |
Acute Myeloid Leukemia | Phase 3 | RO | 01 Jul 2009 | |
Acute Myeloid Leukemia | Phase 3 | ES | 01 Jul 2009 | |
Acute Myeloid Leukemia | Phase 3 | GB | 01 Jul 2009 | |
Diffuse Large B-Cell Lymphoma | Phase 2 | - | - |
Phase 2/3 | 74 | (AZD1152 1200mg) | xiarwjixqs(xugvbfulkm) = hxtohzwzwy xztyelzfhi (jtxqskjixz, uhrwojtgzr - vsorzksvqv) View more | - | 31 Mar 2014 | ||
(LDAC 20mg) | xiarwjixqs(xugvbfulkm) = atkmirfjbe xztyelzfhi (jtxqskjixz, cdhwtyscor - oijtnkdwtg) View more |